Skip to content
← Back to Prescribing

Prescribing

Prednisone burst (asthma/COPD)

Short-course oral steroid dosing for acute exacerbations.

Last reviewed 2026-01-05|respiratory | exacerbation | medication

Editorial feedback

Suggest an update

Flag outdated guidance or propose revised wording for this page. Do not include PHI or patient identifiers.

Open suggestion form

Dosing quick reference

Medication (generic)

Prednisone

Starting dose

40-50 mg once daily for 5-7 days

Typical titration / target

No taper needed for short courses

Monitoring / notes

Review glucose, mood, and sleep effects.

Contraindications

  • Avoid when untreated systemic infection is strongly suspected unless benefits clearly outweigh risks.
  • Avoid repeated bursts without reassessing underlying controller strategy and diagnosis.
  • Reassess risk before use in patients with severe prior steroid adverse effects.

Renal and hepatic considerations

  • No routine renal dose adjustment is typically required for short bursts, but comorbidity may amplify risk.
  • Use extra caution in significant hepatic dysfunction or complex polypharmacy.
  • Review glycemic and fluid-status impact in high-risk metabolic or renal contexts.

Pregnancy and lactation cautions

  • Confirm pregnancy status when relevant and discuss maternal-fetal risk-benefit before prescribing.
  • Use the shortest effective duration when treatment is required.
  • During lactation, align counseling with current guidance and infant monitoring considerations.

Monitoring checkpoints

  • Add inhaled controller optimization and reliever plan at discharge.
  • Provide sick day plan for patients with diabetes or adrenal suppression risk.
  • Confirm follow-up within 1-2 weeks after exacerbation.

Stop or escalate criteria

  • Stop after planned short-course completion unless a clear alternative plan is documented.
  • Escalate for severe mood change, uncontrolled hyperglycemia, infection concern, or poor response.
  • Escalate urgently for worsening dyspnea, hypoxia, or inability to maintain oral intake.